Biotech, Pharmaceutical & Medical Equipment Auctions & Asset Sales

Ongoing modernization within biotech, pharmaceutical, and medical operations results in surplus laboratory, production, and facility assets as research priorities shift, products reach end of life, and manufacturing footprints evolve. Heritage Global Partners has a long track record supporting asset dispositions within this sector for research laboratories, clinical operations, and regulated manufacturing facilities, including surplus laboratory equipment sales and complete facility liquidations, frequently spanning multiple operational sites.

Heritage Global Partners maintains exclusive master service agreements with Pfizer and Amgen for the disposition of surplus biotech and pharmaceutical assets. Sales in this category originate from research and development transitions, facility consolidations, and corporate restructuring, supporting buyers active in regulated scientific and healthcare environments.

Typical Assets Sold

Current Auctions

Past Auctions

Global Online Auction of Quality Assorted Laboratory and Facility Support Assets Excess To Future Operations of Seattle Genetics Inc.

Starting: Jun 5th, 2018 7:00am PDT

Ending: Jun 6th, 2018 10:00am PDT

Immediately Accepting Bids
The 66th in a Series of Online Sales Featuring State-of-the-Art BioPharma Lab Equipment from the World’s Largest Pharmaceutical Manufacturer

Starting: May 30th, 2018 7:00am PDT

Ending: May 31st, 2018 9:00am PDT

Immediately Accepting Bids
Global Online Auction Of Quality Biotech and Pharmaceutical Lab Equipment Excess To Future Needs Of Our Global Sellers!

Starting: May 21st, 2018 7:00am PDT

Ending: May 22nd, 2018 10:00am PDT

Immediately Accepting Bids
The 65th in a Series of Online Sales Featuring State-of-the-Art BioPharma Lab Equipment from the World’s Largest Pharmaceutical Manufacturer

Starting: Apr 25th, 2018 7:00am PDT

Ending: Apr 26th, 2018 9:00am PDT

Immediately Accepting Bids
Global Online Auction Of Quality Biotech and Pharmaceutical Laboratory Equipment Excess To Needs Of Multiple Global Sellers! Burlingame, CA

Starting: Mar 28th, 2018 7:00am PDT

Ending: Mar 30th, 2018 10:00am PDT

Immediately Accepting Bids
The 64th in a Series of Online Sales Featuring State-of-the-Art BioPharma Lab Equipment from the World’s Largest Pharmaceutical Manufacturer

Starting: Mar 28th, 2018 7:00am PDT

Ending: Mar 29th, 2018 9:00am PDT

Immediately Accepting Bids
Global Online Auction Of Late Model Lab Equipment Surplus To Future Operations PharmAkea Therapeutics. San Diego, CA.

Starting: Mar 6th, 2018 9:00am PST

Ending: Mar 7th, 2018 10:00am PST

Immediately Accepting Bids
Global Online Auction of Quality Biotech & Pharmaceutical Lab Equipment Excess To The Needs Of Multiple Global Sellers. Burlingame, CA.

Starting: Feb 17th, 2018 7:00am PST

Ending: Feb 20th, 2018 10:00am PST

Immediately Accepting Bids

Managing surplus lab or regulated manufacturing assets?

Buyer FAQs

Many cleanroom components, HVAC systems, and lab assets can be reused in non-GMP or pilot-scale applications with modification.
Buyers should evaluate service history, manufacturer support status, software compatibility, and calibration requirements.
Validation documentation may be available when provided by the seller and is disclosed within the listing of assets for sale.

Seller FAQs

Sales are often structured to align with internal QA, EHS, and compliance teams prior to equipment release.
Yes. Asset-only dispositions can be structured without referencing product names or research outcomes.

Sales are often driven by pipeline changes, site consolidations, regulatory strategy shifts, or the retirement of specific research or production programs.